Anthony G. Bower
RAND Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anthony G. Bower.
Journal of General Internal Medicine | 2008
Teryl K. Nuckols; Anthony G. Bower; Susan M. Paddock; Lee H. Hilborne; Peggy Wallace; Jeffrey M. Rothschild; Anne Griffin; Rollin J. Fairbanks; Beverly Carlson; Robert J. Panzer; Robert H. Brook
BackgroundPatients in intensive care units (ICUs) frequently experience adverse drug events involving intravenous medications (IV-ADEs), which are often preventable.ObjectivesTo determine how frequently preventable IV-ADEs in ICUs match the safety features of a programmable infusion pump with safety software (“smart pump”) and to suggest potential improvements in smart-pump design.DesignUsing retrospective medical-record review, we examined preventable IV-ADEs in ICUs before and after 2 hospitals replaced conventional pumps with smart pumps. The smart pumps alerted users when programmed to deliver duplicate infusions or continuous-infusion doses outside hospital-defined ranges.Participants4,604 critically ill adults at 1 academic and 1 nonacademic hospital.MeasurementsPreventable IV-ADEs matching smart-pump features and errors involved in preventable IV-ADEs.ResultsOf 100 preventable IV-ADEs identified, 4 involved errors matching smart-pump features. Two occurred before and 2 after smart-pump implementation. Overall, 29% of preventable IV-ADEs involved overdoses; 37%, failures to monitor for potential problems; and 45%, failures to intervene when problems appeared. Error descriptions suggested that expanding smart pumps’ capabilities might enable them to prevent more IV-ADEs.ConclusionThe smart pumps we evaluated are unlikely to reduce preventable IV-ADEs in ICUs because they address only 4% of them. Expanding smart-pump capabilities might prevent more IV-ADEs.
International Journal of Industrial Organization | 1997
Anthony G. Bower; Steven Garber; Joel Watson
Abstract Various reputation models consider how cooperation might emerge between rational adversaries in non-cooperative games. We suggest and analyze an additional determinant: uncertainty and learning about the population from which agents are selected. The analysis shows how the degrees of trust by principals and cooperation by agents can depend on the past behavior of other agents. A dramatic implication is that trust and cooperation can permanently and inefficiently break down due to revised beliefs about the population of agents. We consider lessons the theory might provide concerning the relationship between the U.S. Department of Defense and its contractors. The model suggests two explanations of events during the mid-1980s, which many interpret as a very socially costly breakdown of trust and cooperation.
Medical Care | 2008
Teryl K. Nuckols; Susan M. Paddock; Anthony G. Bower; Jeffrey M. Rothschild; Rollin J. Fairbanks; Beverly Carlson; Robert J. Panzer; Lee H. Hilborne
Background:Adverse drug events (ADEs), particularly those involving intravenous medications (IV-ADEs), are common among intensive care unit (ICU) patients and may increase hospitalization costs. Precise cost estimates have not been reported for academic ICUs, and no studies have included nonacademic ICUs. Objectives:To estimate increases in costs and length of stay after IV-ADEs at an academic and a nonacademic hospital. Research Design:This study reviewed medical records to identify IV-ADEs, and then, using a nested case-control design with propensity-score matching, assessed differences in costs and length of stay between cases and controls. Subjects:A total of 4604 adult ICU patients in 3 ICUs at an academic hospital and 2 ICUs at a nonacademic hospital in 2003 and 2004. Measures:Increased cost and length of stay associated with IV-ADEs. Results:Three hundred ninety-seven IV-ADEs were identified: 79% temporary physical injuries, 0% permanent physical injuries, 20% interventions to sustain life, and 2% in-hospital deaths. In the academic ICUs, patients with IV-ADEs had
Health Affairs | 2005
Richard Hillestad; James H. Bigelow; Anthony G. Bower; Federico Girosi; Robin C. Meili; Richard Scoville; Roger Taylor
6647 greater costs (P < 0.0001) and 4.8-day longer stays (P = 0.0003) compared with controls. In the nonacademic ICUs, IV-ADEs were not associated with greater costs (
Archive | 2005
Richard Hillestad; James H. Bigelow; Anthony G. Bower; Federico Girosi; Robin C. Meili; Richard Scoville; Roger Taylor
188, P = 0.4236) or lengths of stay (−0.3 days, P = 0.8016). Cost and length-of-stay differences between the hospitals were statistically significant (P = 0.0012). However, there were no differences in IV-ADE severity or preventability, and the characteristics of patients experiencing IV-ADEs differed only modestly. Conclusions:IV-ADEs substantially increased hospitalization costs and length of stay in ICUs at an academic hospital but not at a nonacademic hospital, likely because of differences in practices after IV-ADEs occurred.
Health Affairs | 2005
Roger Taylor; Anthony G. Bower; Federico Girosi; James H. Bigelow; Kateryna Fonkych; Richard Hillestad
Law & Society Review | 1999
Steven Garber; Anthony G. Bower
Health Affairs | 2005
Anthony G. Bower
Archive | 2008
Teryl K. Nuckols; Anthony G. Bower; Susan M. Paddock; Lee H. Hilborne; Peggy Wallace; Jeffrey M. Rothschild; Anne Griffin; Rollin J. Fairbanks; Beverly Carlson; Robert J. Panzer; Robert H. Brook
Archive | 2005
Roger Taylor; Anthony G. Bower; Federico Girosi; James H. Bigelow; Katya Fonkych; Richard Hillestad